Hussman Strategic Advisors, Inc. Biocept Inc Transaction History

Hussman Strategic Advisors, Inc.

  • $351 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021
SELL
$3.39 - $4.34 $244,080 - $312,480
-72,000 Closed
0 $0
Q1 2021

May 03, 2021
BUY
$4.74 - $7.94 $324,690 - $543,890
68,500 Added 1957.14%
72,000 $366,000
Q4 2020

Feb 01, 2021
SELL
$4.31 - $6.16 $344,799 - $492,800
-80,000 Reduced 95.81%
3,500 $16,000
Q3 2020

Nov 02, 2020
BUY
$3.61 - $11.4 $301,435 - $951,900
83,500 New
83,500 $368,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email